Skip to main content
. 2023 May 18;47:101223. doi: 10.1016/j.ijcha.2023.101223

Fig. 1.

Fig. 1

The A) effectiveness and B) safety of NOACs versus VKAs in AF patients with a history of falls after IPTW. The weighted number of subjects at risk in the pseudopopulation, weighted number of events, weighted event rates per 100 PY and aHRs with 95%CIs after IPTW are illustrated. aHR: adjusted hazard ratio; CI: confidence interval; IPTW: inverse probability of treatment weighting; NOAC: non-vitamin K antagonist oral anticoagulant; PY: person-years; Ref: reference category; SE: systemic embolism; VKA: vitamin K antagonist; vs: versus.